BioNTech to Host Innovation Series R&D Day on November 14, 2024
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
BioNTech (BNTX) PT Raised to $126 at BMO Capital
November 4, 2024 4:06 PM ESTBMO Capital analyst Etzer Darout raised the price target on BioNTech (NASDAQ: BNTX) to $126.00 (from $122.00) while maintaining a Outperform rating.
The analyst comments "BNTX announced revenues of 1.24B, above FactSet consensus (+142%) and reiterated FY24 guidance of 2.5-3.1B in revenues,... More
BofA Securities Reiterates Buy Rating on BioNTech (BNTX)
November 4, 2024 12:47 PM ESTBofA Securities analyst Tazeen Ahmad reiterated a Buy rating and $150.00 price target on BioNTech (NASDAQ: BNTX).
The analyst comments "BioNTech (BNTX) reported 1.2bn in 3Q COVID revenues ahead of our and consensus 362mn estimates. The company noted this was mainly driven by earlier global... More
